About Biofire Diagnostics
Biofire Diagnostics is a company based in Salt Lake City (United States) founded in 1990 was acquired by Institut Merieux in December 2021.. Biofire Diagnostics has raised $84 million across 6 funding rounds from investors including HHS, BioMerieux and 10X Capital. Biofire Diagnostics offers products and services including BIOFIRE System, Respiratory Panel, and Gastrointestinal Panel. Biofire Diagnostics operates in a competitive market with competitors including ChromaCode, Inflammatix, Visby Medical, MeMed and GenMark Diagnostics, among others.
- Headquarter Salt Lake City, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biofire Diagnostics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$84 M (USD)
in 6 rounds
-
Latest Funding Round
$14 M (USD), Series A
Nov 07, 2022
-
Investors
HHS
& 10 more
-
Employee Count
Employee Count
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biofire Diagnostics
Biofire Diagnostics offers a comprehensive portfolio of products and services, including BIOFIRE System, Respiratory Panel, and Gastrointestinal Panel. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Multiplex PCR system for rapid infectious disease testing.
Detects viruses and bacteria in respiratory samples.
Identifies pathogens in gastrointestinal infections.
Funding Insights of Biofire Diagnostics
Biofire Diagnostics has successfully raised a total of $84M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $14 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series A — $14.0M
-
First Round
First Round
(19 Sep 2012)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Series A - Biofire Diagnostics | Valuation | Founders Fund | |
| Mar, 2015 | Amount | Grant - Biofire Diagnostics | Valuation |
investors |
|
| Aug, 2014 | Amount | Grant - Biofire Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biofire Diagnostics
Biofire Diagnostics has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, BioMerieux and 10X Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology and defense sectors.
|
Founded Year | Domain | Location | |
|
Access to private investment strategies is provided for institutional investors.
|
Founded Year | Domain | Location | |
|
Venture capital investing with a focus on diversity and inclusion in the ecosystem.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biofire Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biofire Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biofire Diagnostics Comparisons
Competitors of Biofire Diagnostics
Biofire Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChromaCode, Inflammatix, Visby Medical, MeMed and GenMark Diagnostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital molecular biology analytics are developed for disease management.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Instruments and test panels for multiplexed molecular diagnostics are provided.
|
|
| domain | founded_year | HQ Location |
Point-of-care molecular platforms for infectious disease detection are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biofire Diagnostics
Frequently Asked Questions about Biofire Diagnostics
When was Biofire Diagnostics founded?
Biofire Diagnostics was founded in 1990 and raised its 1st funding round 22 years after it was founded.
Where is Biofire Diagnostics located?
Biofire Diagnostics is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Is Biofire Diagnostics a funded company?
Biofire Diagnostics is a funded company, having raised a total of $84M across 6 funding rounds to date. The company's 1st funding round was a Grant of $168K, raised on Sep 19, 2012.
What does Biofire Diagnostics do?
Biofire Diagnostics was founded in 1990 and is headquartered in Salt Lake City, United States. Operations center on the molecular diagnostics sector, where new assays are developed for the proprietary FilmArray System, a multiplex PCR platform. Panels offered include Respiratory (RP), Blood Culture Identification (BCID), Gastrointestinal (GI), and MeningitisEncephalitis (ME) tests for pathogen detection.
Who are the top competitors of Biofire Diagnostics?
Biofire Diagnostics's top competitors include ChromaCode, Visby Medical and Inflammatix.
What products or services does Biofire Diagnostics offer?
Biofire Diagnostics offers BIOFIRE System, Respiratory Panel, and Gastrointestinal Panel.
Who are Biofire Diagnostics's investors?
Biofire Diagnostics has 11 investors. Key investors include HHS, BioMerieux, 10X Capital, Institut Mérieux, and Gavin de Becker and Associates.